Quick answer: Tesamorelin is a 44-amino-acid, stabilised analogue of growth-hormone-releasing hormone (GHRH). It stimulates the pituitary to release your own growth hormone and is the only GHRH peptide with an FDA approval, granted for reducing excess abdominal (visceral) fat in a specific patient group. It is studied for visceral fat, body composition, metabolic health and cognition. At Summit Health Clinic in Springfield, MO, it is prescribed after lab work and a provider evaluation, most often for stubborn belly fat.
What is Tesamorelin?
Tesamorelin is the full 44 amino acid GHRH molecule with a small chemical modification at one end that protects it from being broken down in the blood. That change gives it a stronger and longer-lasting effect than Sermorelin, its shorter cousin. It was approved by the FDA in 2010 under the brand name Egrifta for reducing visceral abdominal fat in people with HIV associated lipodystrophy, which makes it one of the best-studied peptides in human trials. Outside that approved use, it is prescribed off-label for body composition and metabolic goals along with Growth Hormone optimization.
How does Tesamorelin work?
Pituitary stimulation. Like natural GHRH, it binds pituitary receptors and triggers release of growth hormone in physiological pulses, with the body's own feedback controls intact.
IGF-1 and fat metabolism. The resulting rise in growth hormone and IGF-1 increases lipolysis, the breakdown of stored fat, with a particular effect on visceral fat around the organs.
Liver fat. Human studies show reductions in liver fat, a marker closely tied to insulin resistance and metabolic disease.
Cognition. In older adults, Tesamorelin improved measures of executive function and memory in a controlled trial, likely through IGF-1 effects in the brain.
What are the potential benefits of Tesamorelin?
Visceral fat reduction. In clinical trials it reduced visceral abdominal fat by roughly 15 to 20 percent over six months, the strongest body-composition evidence of any peptide we offer.
Metabolic health. Lower liver fat and improved triglycerides.
Lean mass preservation. Growth-hormone support helps protect muscle during fat loss.
Cognitive support. Early evidence for sharper thinking in healthy older adults.
Recovery and sleep. The general growth-hormone benefits also seen with Sermorelin.
Evidence note: Tesamorelin has multiple randomised controlled trials behind it, which is rare in this field. Results in people without lipodystrophy are expected to be similar in direction but have been studied less, and effects reverse if therapy stops without lifestyle changes in place.
How is Tesamorelin taken?
Tesamorelin is given by a small subcutaneous injection once daily, usually in the evening, with an insulin-style needle. Courses typically run three to six months, with IGF-1, metabolic labs and body-composition scans tracked along the way.
Why Summit Health uses Tesamorelin
Abdominal fat is the type most linked to heart disease, diabetes and fatty liver, and it is often the last to respond to diet and exercise. Tesamorelin is our most targeted tool for it. We use it for patients who have made real lifestyle progress and still carry visceral fat, for those on medical weight loss who want to protect muscle, and alongside testosterone optimisation. We measure the result with body composition scans rather than guessing. Every protocol starts with lab work and a visit with Scott Adler, PA-C, and is filled through a licensed U.S. pharmacy.
Tesamorelin frequently asked questions
What is the difference between Tesamorelin and Sermorelin?
Both stimulate your own growth hormone. Tesamorelin is longer-acting and more potent, with specific trial evidence for visceral fat. Sermorelin is gentler and used more for general recovery, sleep and healthy ageing. Some patients start with Sermorelin and move to Tesamorelin when belly fat is the primary goal.
How long does Tesamorelin take to work?
Measurable reductions in visceral fat typically appear by three months, with the full effect at six. Sleep and recovery changes come sooner.
Is Tesamorelin safe?
Its safety profile is well documented from clinical trials. The most common side effects are injection-site reactions, joint aches and fluid retention, which usually settle. It is not used in pregnancy, active cancer or in patients with pituitary disease, and we monitor IGF-1 and blood sugar during therapy.
Will the fat come back if I stop?
In trials, visceral fat returned over the months after stopping when nothing else changed. That is why we pair Tesamorelin with nutrition, strength training and, where appropriate, other therapies, so the gains have something to stand on.
This article is for educational purposes and is not medical advice. Tesamorelin is prescribed after a provider evaluation and, outside its FDA-approved indication, is used off-label. It is not intended to diagnose, treat, cure or prevent any disease. Individual results vary. To find out whether it fits your goals, book a consultation or call or text (417) 232-3000.